June 8, 2020 / 1:32 PM / a month ago

BRIEF-Alpine Immune Sciences Provides Clinical Update Of Phase 1 Trial Of ALPN-101 In Healthy Volunteers

June 8 (Reuters) - Alpine Immune Sciences Inc:

* ALPINE IMMUNE SCIENCES PROVIDES CLINICAL UPDATE OF ITS PHASE 1 TRIAL OF ALPN-101 IN HEALTHY VOLUNTEERS AT THE EUROPEAN LEAGUE AGAINST RHEUMATISM (EULAR) E-CONGRESS 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below